Terms: = Liver cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
19 results:
1. Bioinformatic Analysis and Computer-Aided Study to Investigate the Potential Application of a Bioflavonoid Compound Bilobetin in liver cancer Treatment.
Zhang C; Sui Y; Liu S; Yang M
Front Biosci (Landmark Ed); 2023 Dec; 28(12):360. PubMed ID: 38179744
[TBL] [Abstract] [Full Text] [Related]
2. The CDCP1 Signaling Hub: A Target for cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract] [Full Text] [Related]
3. MUC Glycoproteins: Potential Biomarkers and Molecular Targets for cancer Therapy.
Ratan C; Cicily K D D; Nair B; Nath LR
Curr Cancer Drug Targets; 2021; 21(2):132-152. PubMed ID: 33200711
[TBL] [Abstract] [Full Text] [Related]
4. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-src signaling.
Wang T; Jin H; Hu J; Li X; Ruan H; Xu H; Wei L; Dong W; Teng F; Gu J; Qin W; Luo X; Hao Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):148. PubMed ID: 32746865
[TBL] [Abstract] [Full Text] [Related]
5. Peptide SMIM30 promotes HCC development by inducing src/YES1 membrane anchoring and MAPK pathway activation.
Pang Y; Liu Z; Han H; Wang B; Li W; Mao C; Liu S
J Hepatol; 2020 Nov; 73(5):1155-1169. PubMed ID: 32461121
[TBL] [Abstract] [Full Text] [Related]
6. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS
J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913
[TBL] [Abstract] [Full Text] [Related]
7. miR24-2 Promotes Malignant Progression of Human liver cancer Stem Cells by Enhancing Tyrosine Kinase src Epigenetically.
Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of PSMD4 blocks the tumorigenesis of hepatocellular carcinoma.
Cai MJ; Cui Y; Fang M; Wang Q; Zhang AJ; Kuai JH; Pang F; Cui XD
Gene; 2019 Jun; 702():66-74. PubMed ID: 30930224
[TBL] [Abstract] [Full Text] [Related]
9. Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase-2 in hepatocellular carcinoma cells and inhibits cell invasion.
Liu Y; Zhang X; Zhou S; Shi J; Xu Y; He J; Lin F; Wei A; Zhou L; Chen Z
J Cell Mol Med; 2019 Apr; 23(4):2399-2409. PubMed ID: 30677226
[TBL] [Abstract] [Full Text] [Related]
10. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
[TBL] [Abstract] [Full Text] [Related]
11. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
Brümmendorf TH; Cortes JE; Khoury HJ; Kantarjian HM; Kim DW; Schafhausen P; Conlan MG; Shapiro M; Turnbull K; Leip E; Gambacorti-Passerini C; Lipton JH
Br J Haematol; 2016 Jan; 172(1):97-110. PubMed ID: 26537529
[TBL] [Abstract] [Full Text] [Related]
12. Primary Linitis Plastica of the Rectum: Focus on Magnetic Resonance Imaging Patterns and Treatment Options.
Boustani J; Kim S; Lescut N; Lakkis Z; de Billy M; Arbez-Gindre F; Jary M; Borg C; Bosset JF
Am J Case Rep; 2015 Aug; 16():581-5. PubMed ID: 26322720
[TBL] [Abstract] [Full Text] [Related]
13. Transforming growth factor β-interacting factor-induced malignant progression of hepatocellular carcinoma cells depends on superoxide production from Nox4.
Liu ZM; Tseng HY; Tsai HW; Su FC; Huang HS
Free Radic Biol Med; 2015 Jul; 84():54-64. PubMed ID: 25841779
[TBL] [Abstract] [Full Text] [Related]
14. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
PLoS One; 2014; 9(9):e110067. PubMed ID: 25268648
[TBL] [Abstract] [Full Text] [Related]
15. Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells.
Gurbuz N; Ashour AA; Alpay SN; Ozpolat B
PLoS One; 2014; 9(8):e105245. PubMed ID: 25170871
[TBL] [Abstract] [Full Text] [Related]
16. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
Piessen G; Messager M; Lefevre JH; Goéré D; Mabrut JY; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C;
Eur J Surg Oncol; 2014 Dec; 40(12):1746-55. PubMed ID: 25012732
[TBL] [Abstract] [Full Text] [Related]
17. Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.
Li M; Zhu M; Li W; Lu Y; Xie X; Wu Y; Zheng S
Cancer Lett; 2013 Apr; 330(2):170-80. PubMed ID: 23211536
[TBL] [Abstract] [Full Text] [Related]
18. Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model.
Lu JW; Hsia Y; Yang WY; Lin YI; Li CC; Tsai TF; Chang KW; Shieh GS; Tsai SF; Wang HD; Yuh CH
Carcinogenesis; 2012 Jan; 33(1):209-19. PubMed ID: 22021908
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results.
Wang F; Anderson PW; Salem N; Kuang Y; Tennant BC; Lee Z
Int J Oncol; 2007 Jan; 30(1):33-44. PubMed ID: 17143510
[TBL] [Abstract] [Full Text] [Related]
